Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘17
426
21 61 40 310%
427
21 326 305 298%
428
21 88 67 15.7%
LCTX icon
429
Lineage Cell Therapeutics
LCTX
$451M
21 39 18 35.1%
430
21 135 114 79.5%
431
21 48 27 10.1%
432
21 95 74 53.5%
433
21 48 27 28.8%
434
21 79 58 27.8%
435
21 125 104 116%
FEM icon
436
First Trust Emerging Markets AlphaDEX Fund
FEM
$625M
21 31 10 36.2%
437
21 71 50 227%
438
21 50 29 48.7%
439
21 35 14 88.4%
440
21 223 202 6.91%
441
21 92 71 7.35%
442
21 89 68 86.5%
443
21 71 50 128%
444
21 105 84 38.1%
445
21 189 168 38.8%
446
21 95 74 64%
447
21 54 33 71.6%
448
21 76 55 49.7%
449
21 57 36 99.6%
450
21 47 26 58.4%